Berkshire Biomedical
About this raise
Berkshire Biomedical, with a valuation of $23.28 million, is raising funds on StartEngine. It is a medical technology company focused on developing personalized medication management systems. Berkshire Biomedical’s flagship product, COPA, is designed to provide biometric-controlled dispensing of liquid oral medications and help improve medication adherence and treatment outcomes. The business has received a $2 million NIH research grant and is currently in the pre-revenue phase. Thomas Rouse founded Berkshire Biomedical in July 2016. The current crowdfunding campaign has a minimum target of $20,000 and a maximum target of $1.5 million. The campaign proceeds will be used for FDA application and working capital.
Investment Overview
Committed : $330,236
Deal Terms
Total Commitments
- Platform
- StartEngine
- Start Date
- 02/25/2025
- Close Date
- 04/30/2025
$20,000
$1,500,000
$400
Equity - Preferred
Seed
RegCF
$8.00
$23,277,472
Company & Team
Company
- Year Founded
- 2016
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B2C
- Margin
- Medium
- Capital Intensity
- High
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $11,968,292
- Grants
- $2,000,000
- VC Backed?
- No
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 04/30/2025 | StartEngine | $23,277,472 | $330,236 | Equity - Preferred | Active | RegCF |